Hollis R. Chaney

Hollis R. Chaney

Pediatric Pulmonology

9850 Key West Avenue
Rockville, MD 20850

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Bacteriophage Therapy for Pan-Drug-Resistant Pseudomonas aeruginosa in Two Persons With Cystic Fibrosis.

Bacteriophage Therapy for Pan-Drug-Resistant Pseudomonas aeruginosa in Two Persons With Cystic Fibrosis.

Journal: Journal of investigative medicine high impact case reports

Published: July 29, 2023

Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosis.

Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosis.

Journal: Frontiers in medicine

Published: October 27, 2022

Key4OI Recommendations for Lung Function Guidance in Osteogenesis Imperfecta: Based on an Internationally Performed Comprehensive International Consortium for Health Outcomes Measurement Procedure.

Key4OI Recommendations for Lung Function Guidance in Osteogenesis Imperfecta: Based on an Internationally Performed Comprehensive International Consortium for Health Outcomes Measurement Procedure.

Journal: Chest

Published: August 30, 2022

Impact of Antibiotics on the Lung Microbiome and Lung Function in Children With Cystic Fibrosis 1 Year After Hospitalization for an Initial Pulmonary Exacerbation.

Impact of Antibiotics on the Lung Microbiome and Lung Function in Children With Cystic Fibrosis 1 Year After Hospitalization for an Initial Pulmonary Exacerbation.

Journal: Open forum infectious diseases

Published: June 06, 2022

Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosis.

Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosis.

Journal: Scientific reports

Published: May 24, 2022

Measuring the impact of an empiric antibiotic algorithm for pulmonary exacerbation in children and young adults with cystic fibrosis.

Measuring the impact of an empiric antibiotic algorithm for pulmonary exacerbation in children and young adults with cystic fibrosis.

Journal: Pediatric pulmonology

Published: October 14, 2021

Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Airway Microbiome Diversity and Pulmonary Function.

Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Airway Microbiome Diversity and Pulmonary Function.

Journal: The Pediatric infectious disease journal

Published: July 16, 2021

Importance of beta-lactam pharmacokinetics and pharmacodynamics on the recovery of microbial diversity in the airway of persons with cystic fibrosis.

Importance of beta-lactam pharmacokinetics and pharmacodynamics on the recovery of microbial diversity in the airway of persons with cystic fibrosis.

Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research

Published: April 27, 2021

Inflammation in children with cystic fibrosis: contribution of bacterial production of long-chain fatty acids.

Inflammation in children with cystic fibrosis: contribution of bacterial production of long-chain fatty acids.

Journal: Pediatric research

Published: August 06, 2020

Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation.

Airway microbial diversity is decreased in young children with cystic fibrosis compared to healthy controls but improved with CFTR modulation.

Journal: Heliyon

Published: October 11, 2019

Relationship of Pulmonary Outcomes, Microbiology, and Serum Antibiotic Concentrations in Cystic Fibrosis Patients.

Relationship of Pulmonary Outcomes, Microbiology, and Serum Antibiotic Concentrations in Cystic Fibrosis Patients.

Journal: The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

Published: November 16, 2018

Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosis.

Changes in microbiome diversity following beta-lactam antibiotic treatment are associated with therapeutic versus subtherapeutic antibiotic exposure in cystic fibrosis.

Journal: Scientific reports

Published: November 01, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026